APA
Click to copy
M*, H., A*, T., D*, S., GK*, S., HL, B., KA, W., … co-lead authors), E. L. M. (*. (2026). N-Propargylglycine restores survival by preventing calcium oxalate stone formation, tubular injury, and kidney dysfunction in a lethal mouse model of primary hyperoxaluria type 2. Kidney International, S0085-2538(26). https://doi.org/10.1016/j.kint.2026.02.024
Chicago/Turabian
Click to copy
M*, Hady, Tadeo A*, Stoyanova D*, Scott GK*, Baker HL, Wilson KA, Ingle H, et al. “N-Propargylglycine Restores Survival by Preventing Calcium Oxalate Stone Formation, Tubular Injury, and Kidney Dysfunction in a Lethal Mouse Model of Primary Hyperoxaluria Type 2.” Kidney International S0085-2538, no. 26 (2026).
MLA
Click to copy
M*, Hady, et al. “N-Propargylglycine Restores Survival by Preventing Calcium Oxalate Stone Formation, Tubular Injury, and Kidney Dysfunction in a Lethal Mouse Model of Primary Hyperoxaluria Type 2.” Kidney International, vol. S0085-2538, no. 26, 2026, doi:10.1016/j.kint.2026.02.024.
BibTeX Click to copy
@article{hady2026a,
title = {N-Propargylglycine restores survival by preventing calcium oxalate stone formation, tubular injury, and kidney dysfunction in a lethal mouse model of primary hyperoxaluria type 2},
year = {2026},
issue = {26},
journal = {Kidney International},
volume = {S0085-2538},
doi = {10.1016/j.kint.2026.02.024},
author = {M*, Hady and A*, Tadeo and D*, Stoyanova and GK*, Scott and HL, Baker and KA, Wilson and H, Ingle and PVA, Kumaar and BD, Ambrose and B, Schilling and CC, Benz and co-lead authors), Ellerby LM (*}
}